公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study | Shao Z.; Tseng L.-M.; CHIUN-SHENG HUANG ; Pang D.; Yang Y.; Li W.; Liao N.; Geng C.; Zhang Q.; Xu B.; Liu D.; Kwong A.; et al (continued in the appendix) | Japanese journal of clinical oncology | 2 | 1 | |
2021 | A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer | YEN-SHEN LU ; Lee K.S.; Chao T.-Y.; Tseng L.-M.; Chitapanarux I.; Chen S.-C.; Liu C.-T.; Sohn J.; Kim J.H.; Chang Y.-C.; Yang Y.; Shotelersuk K.; Jung K.H.; Valenti R.; Slader C.; Gao M.; Park Y.H. | Clinical Cancer Research | 23 | 16 | |
2011 | Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer | YEN-SHEN LU ; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer Chemotherapy and Pharmacology | 10 | 8 | |
2014 | Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30 | Cramarossa G.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Lam H.; Pulenzas N.; Chow E. | Expert Review of Pharmacoeconomics and Outcomes Research | 7 | 7 | |
2013 | Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30 | Lam K.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Pharmd F.F.; WEI-CHU CHIE ; Sahgal A.; Poon M.; Chow E. | Journal of Palliative Medicine | 11 | 10 | |
2012 | Quality of life after palliative radiation therapy for patients with painful bone metastases: Results of an international study validating the EORTC QLQ-BM22 | Zeng L.; Chow E.; Bedard G.; Zhang L.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | International Journal of Radiation Oncology Biology Physics | 80 | 68 | |
2013 | Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid | Chao T.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Yeh D.-C.; Wang H.-C.; Huang W.-T.; Rau K.-M.; KING-JEN CHANG ; Yang T.-L.; Lee K.-D.; Tai C.-J.; Tseng L.-M.; Hou M.-F. | Anticancer Research | 1 | ||
2013 | Reduction of the noise in the respiration sound recording by the optimal sampling rate of sound card: A preliminary study | Lu B.-Y.; JIN-SHIN LAI ; HUEY-DONG WU ; Chen Y.-R.; Weng Y.-L.; Tang S.-H.; Chen Y.-L.; Tseng L.-M. | International Conference on Advanced Communication Technology, ICACT | |||
2021 | Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature | Huang C.-S.; TZU-PIN LU ; Liu C.-Y.; Huang C.-J.; Chiu J.-H.; Chen Y.-J.; Tseng L.-M.; Huang C.-C. | Breast Cancer Research and Treatment | 4 | 4 | |
2012 | ROCKII Ser 1366 phosphorylation reflects the activation status | Chuang H.-H.; Yang C.-H.; Tsay Y.-G.; Hsu C.-Y.; Tseng L.-M.; ZEE-FEN CHANG ; Lee H.-H. | Biochemical Journal | 32 | 30 | |
2016 | Symptom clusters analysis in bone metastases patients | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.; Lam H.; Bottomley A. | Cancer: Pain and Symptom Management | 0 | ||
2013 | Symptom clusters analysis in bone metastases patients using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases Module (EORTC QLQ-BM22) | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.Y.; Lam H.; Bottomley A. | Journal of Pain Management | 0 | ||
2021 | Targeted sequencing of taiwanese breast cancer with risk stratification by the concurrent genes signature: A feasibility study | Huang C.-S.; Liu C.-Y.; TZU-PIN LU ; Huang C.-J.; Chiu J.-H.; Tseng L.-M.; Huang C.-C. | Journal of Personalized Medicine | 2 | 2 | |
2018 | Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction | Wei P.-L.; Lee L.-T.; Tseng L.-M.; KAI-WEN HUANG | Scientific Reports | 5 | 7 | |
2019 | Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells | Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN ; Dai M.-S.; Tseng L.-M. | Cancers | 23 | 22 |